Published in Obes Surg on March 12, 2009
Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest (2011) 3.08
Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One (2010) 1.44
Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab Invest (2013) 1.41
Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol (2010) 1.11
Liver and diabetes. A vicious circle. Hepatol Res (2013) 1.10
Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metab Rev (2011) 1.07
Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). J Transl Med (2013) 0.88
Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice. Lipids Health Dis (2012) 0.86
Transcriptomic analysis of hepatic responses to testosterone deficiency in miniature pigs fed a high-cholesterol diet. BMC Genomics (2015) 0.84
Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model. Biomed Rep (2012) 0.81
The Bioenergetic Health Index is a sensitive measure of oxidative stress in human monocytes. Redox Biol (2015) 0.80
Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells. Lipids Health Dis (2014) 0.78
Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity. Nutr Diabetes (2015) 0.77
Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD. Mediators Inflamm (2013) 0.76
Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation. World J Gastroenterol (2014) 0.76
Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis. PLoS One (2017) 0.75
The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology (2002) 5.70
Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol (2008) 3.23
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol (2008) 2.87
Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol (2008) 2.61
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut (2010) 2.46
Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis (2007) 2.41
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg (2008) 2.20
Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol (2012) 2.11
Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. Dig Dis Sci (2012) 2.11
Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology (2005) 2.07
Health-related quality of life in patients with chronic hepatitis B. Liver Int (2007) 1.90
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology (2011) 1.81
MELD fails to measure quality of life in liver transplant candidates. Liver Transpl (2005) 1.79
A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Obes Surg (2011) 1.79
Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int (2008) 1.74
Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve Clin J Med (2008) 1.72
Non-invasive markers for hepatic fibrosis. BMC Gastroenterol (2011) 1.65
A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology (2007) 1.54
Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg (2005) 1.52
A methodology for successfully producing global translations of patient reported outcome measures for use in multiple countries. Value Health (2009) 1.50
Toward more transparent and reproducible omics studies through a common metadata checklist and data publications. OMICS (2014) 1.49
When and how to evaluate mildly elevated liver enzymes in apparently healthy patients. Cleve Clin J Med (2010) 1.48
Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol (2007) 1.46
Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics (2008) 1.44
Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples. BMC Mol Biol (2010) 1.42
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol (2012) 1.40
Resource utilization and survival among Medicare patients with advanced liver disease. Dig Dis Sci (2014) 1.40
Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol (2002) 1.34
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol (2004) 1.32
A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology (2005) 1.29
Economic model of a birth cohort screening program for hepatitis C virus. Hepatology (2012) 1.28
Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. J Biol Chem (2006) 1.28
Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol (2007) 1.27
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2009) 1.25
Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int (2007) 1.24
Manifestations of chronic hepatitis C virus infection beyond the liver. Clin Gastroenterol Hepatol (2010) 1.17
Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci (2007) 1.17
Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int (2005) 1.13
Risk factors for hepatocellular carcinoma in patients with cirrhosis. Dig Dis Sci (2004) 1.11
Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol (2010) 1.11
Effects of weight loss on nonalcoholic fatty liver disease. Semin Liver Dis (2008) 1.06
Obesity-related differential gene expression in the visceral adipose tissue. Obes Surg (2005) 1.06
Depression, anemia and health-related quality of life in chronic hepatitis C. J Hepatol (2005) 1.04
Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index. Liver Transpl (2008) 1.04
A network-based approach to prioritize results from genome-wide association studies. PLoS One (2011) 1.03
Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obes Surg (2006) 1.03
The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ). Qual Life Res (2008) 1.02
Pathologic assessment of non-alcoholic fatty liver disease. Clin Liver Dis (2007) 1.01
Treatment regimens for non-alcoholic fatty liver disease. Ann Hepatol (2009) 0.99
Evidence for the ectopic synthesis of melanin in human adipose tissue. FASEB J (2008) 0.98
Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics (2011) 0.98
What is hidden in the pannexin treasure trove: the sneak peek and the guesswork. J Cell Mol Med (2006) 0.98
Adipose tissue as an endocrine organ. Clin Liver Dis (2014) 0.98
Effective antiprotease-antibiotic treatment of experimental anthrax. BMC Infect Dis (2005) 0.96
Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin. Hepatology (2009) 0.96
Obesity-associated nonalcoholic fatty liver disease. Clin Liver Dis (2013) 0.96
Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors. BMC Microbiol (2006) 0.95
Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci (2013) 0.95
PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling. J Cell Mol Med (2007) 0.93
A comparative analysis of relative occurrence of transcription factor binding sites in vertebrate genomes and gene promoter areas. Bioinformatics (2005) 0.93
Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest (2004) 0.93
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia. Cleve Clin J Med (2004) 0.93
Protein partners of KCTD proteins provide insights about their functional roles in cell differentiation and vertebrate development. Bioessays (2013) 0.91
Recent trends in inpatient mortality and resource utilization for patients with stroke in the United States: 2005-2009. J Stroke Cerebrovasc Dis (2013) 0.90
Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. Obes Surg (2010) 0.90
Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin Liver Dis (2009) 0.89
Metabolic syndrome after laparoscopic bariatric surgery. Obes Surg (2008) 0.89
Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy. J Biol Chem (2008) 0.89
Association of chronic liver disease with depression: a population-based study. Psychosomatics (2013) 0.88
Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2013) 0.88